Amanda Pilling PhD
@APilling111
Followers
22
Following
12
Media
1
Statuses
19
Scientist. Translational Oncology.
Detroit, MI
Joined November 2019
RT @oncodaily: ASCO Living Guidelines for NSCLC Without a Driver Alteration - @FawziAbuRous . @ASCO . #OncoDaily #….
0
3
0
Delighted to share our team's latest work- A review of the unique metabolic landscape in ALK+ lung cancer:. ☑️Metabolic reprogramming in TKI resistance. ☑️Potential strategies to target metabolic . vulnerabilities.
0
1
0
RT @LungCancerRx: BIG NEWS at #ASCO25:.@LungCancerRx is launching its first-ever podcast!. Join us for a LIVE recording with @jillfeldman4….
0
5
0
RT @christine_lovly: The @ALKPositiveinc summit is always one of my favorite events of the year! Totally inspiring community + ALK family!….
0
4
0
RT @lungoncdoc: Patients with #cancer deserve clear, accessible treatment information to make informed decisions. Grateful to co-author th….
0
51
0
RT @ChristianRolfo: Keynote speaker at #HTTR24 Dr. Trever Bivona @BivonaLabUCSF discussing about the mechanisms involved in tolerance and R….
0
9
0
RT @allisonoconn: I look at this screen everyday and it took me until now to realize the continent is actually a cow. .
0
117
0
There’s still time to donate to help support critical programs and research at Henry Ford Cancer! 💙🔬🧬 #GameOnCancer .
0
0
1
RT @HenryFordHealth: Join us on Nov. 22 for our 2nd annual thoracic #symposium where our experts will discuss the importance of lung #Cance….
0
1
0
I am running in the Detroit Free Press 5K to support Game on Cancer. Donate to my team! Any amount of support is appreciated and all donations go directly to #GameOnCancer 💙.
0
0
1
Postdoc Opportunity: Are you interested in oncogene-driven lung cancer and drug resistance? Join our team of clinical and translational scientists dedicated to advancing precision oncology for patients with #lungcancer. #lcsm #AcademicTwitter.
henryford.referrals.selectminds.com
GENERAL SUMMARY: Under the direction of a senior investigator, designs, executes, analyzes, and interprets various laboratory experiments with a...
0
0
1
RT @StephenVLiu: Retrospective longitudinal ctDNA analysis in #EGFR NSCLC receiving osimertinib on FLAURA and AURA trials @JTOonline. ctDNA….
0
22
0
RT @StephenVLiu: Impact of #ALK fusion variants @JTOonline. The specific fusion breakpoint has a profound impact. Variant 1 accounts for 50….
0
36
0
RT @RogersLabUCD: There are 3 options one can choose when grants never get funded:.1. Do the same thing again and fail. 2. Give up and lea….
0
3
0
The struggle of being Team Metric by day, where everything makes sense.
0
0
1
RT @jrm_black: New review out in @trendscancer from Chris Abbosh and @CharlesSwanton. Excellent summary of latest evidence & use case for c….
0
6
0
RT @OncoAlert: Lung #cancer 🫁is the 2⃣nd most commonly diagnosed cancer worldwide. In the US🇺🇸 #NSCLC accounts for 8⃣1⃣% of cases. 238,34….
0
38
0